PET/CT imaging in cancer: current applications and future directions
MD Farwell, DA Pryma, DA Mankoff - Cancer, 2014 - Wiley Online Library
Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …
PET imaging in oncology
R Bar-Shalom, AY Valdivia, MD Blaufox - Seminars in nuclear medicine, 2000 - Elsevier
The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …
FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions
J Aoki, H Watanabe, T Shinozaki, K Takagishi… - Radiology, 2001 - pubs.rsna.org
PURPOSE: To evaluate the standardized uptake value (SUV) of 2-[fluorine-18] fluoro-2-
deoxy-d-glucose (FDG) at positron emission tomography (PET) in the differentiation of …
deoxy-d-glucose (FDG) at positron emission tomography (PET) in the differentiation of …
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy
C Franzius, J Sciuk, HE Daldrup-Link… - European journal of …, 2000 - Springer
The purpose of this study was to compare positron emission tomography using fluorine-18
fluorodeoxyglucose (FDG-PET) and technetium-99m methylene diphosphonate (MDP) bone …
fluorodeoxyglucose (FDG-PET) and technetium-99m methylene diphosphonate (MDP) bone …
Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET
M Schulte, D Brecht-Krauss, B Heymer… - Journal of Nuclear …, 2000 - Soc Nuclear Med
Clinical diagnosis of skeletal tumors can be difficult, because such lesions compose a large,
heterogeneous group of entities with different biologic behaviors. The aim of this prospective …
heterogeneous group of entities with different biologic behaviors. The aim of this prospective …
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT
C Franzius, HE Daldrup-Link, J Sciuk, EJ Rummeny… - Annals of …, 2001 - Elsevier
Background The purpose was the comparison of positron emission tomography using F-18-
fluorodeoxy-glucose (FDG-PET) and spiral thoracic CT to detect pulmonary metastases from …
fluorodeoxy-glucose (FDG-PET) and spiral thoracic CT to detect pulmonary metastases from …
PET imaging of osteosarcoma
W Brenner, KH Bohuslavizki… - Journal of Nuclear …, 2003 - Soc Nuclear Med
During the past decade the clinical value of PET imaging has been investigated for many
different tumors. As knowledge of the advantages and limitations of this modality increased …
different tumors. As knowledge of the advantages and limitations of this modality increased …
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma
AL Folpe, RH Lyles, JT Sprouse, EU Conrad III… - Clinical cancer …, 2000 - AACR
Positron emission tomography (PET) can be used to measure tumor metabolism in
sarcomas by measuring the standard uptake value (SUV) of (F-18) fluorodeoxyglucose …
sarcomas by measuring the standard uptake value (SUV) of (F-18) fluorodeoxyglucose …
[HTML][HTML] Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies
F Liu, Q Zhang, D Zhou, J Dong - BMC cancer, 2019 - Springer
Background Multiple trials have attempted to assess the diagnostic value of 18 F-
fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG …
fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG …
The role of quantitative 18F-FDG PET studies for the differentiation of malignant and benign bone lesions
A Dimitrakopoulou-Strauss, LG Strauss… - Journal of Nuclear …, 2002 - Soc Nuclear Med
The role of quantitative 18F-FDG PET studies for the differentiation of benign and malignant
bone lesions is still an open question. Methods: Our evaluation included 83 patients with 37 …
bone lesions is still an open question. Methods: Our evaluation included 83 patients with 37 …